# 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine

> **NCT03578354** · PHASE2 · WITHDRAWN · sponsor: **Massachusetts Eye and Ear Infirmary**

## Conditions studied

- Vestibular Migraine
- Migraine Disorders
- Vestibular Diseases

## Interventions

- **DRUG:** 4-aminopyridine
- **DRUG:** Atenolol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03578354
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-01
- **Primary completion:** 2023-01
- **Final completion:** 2024-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding not acquired
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03578354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03578354, "4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03578354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*